ALPHA (psychedelic)
From Wikipedia, the free encyclopedia
|
ALPHA (psychedelic)
|
|
| Systematic (IUPAC) name | |
| 1-(benzo[1,3]dioxol-5-yl)propan-1-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | ? |
| Chemical data | |
| Formula | C10H13NO2 |
| Mol. mass | 179.22 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half life | ? |
| Excretion | Renal |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | Oral |
ALPHA or alpha-ethyl-3,4-methylenedioxybenzylamine, is a lesser-known psychedelic drug and a substituted benzylamine. It is also the benzylamine analogue of MDA. ALPHA was first synthesized by Alexander Shulgin. In his book PIHKAL (Phenethylamines I Have Known and Loved) in the MDA page, the threshold dosage is listed as 10 mg. At mild threshold dosages (around 10 mg) there are eyes-closed "dreams" with some body tingling, at higher doses (up to 140 mg) was reported to produce a pleasant, positive feeling. This compound is not anoretic at any dose. It lasts about 3 hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of ALPHA.

